Preston Klassen, Metacrine CEO

An­oth­er NASH play­er re­treats from bat­tered field af­ter tox­i­col­o­gy study flags po­ten­tial de­lay

NASH, the no­to­ri­ous liv­er dis­ease af­flict­ing an in­creas­ing num­ber of Amer­i­cans, has al­ways been the fo­cus at Metacrine ever since se­r­i­al en­tre­pre­neur Rich Hey­man un­veiled …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.